Tacrine modulates Kv2.1 channel gene expression and cell proliferation

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Tacrine is known as a cholinesterase (ChE) inhibitor with activity on multiple targets, including nicotinic receptors (nAChRs) and voltage-gated K+ (Kv) channels.
• Kv2.1 channels are highly expressed in the mammalian brain, particularly the hippocampus, and are involved in delayed rectifier currents.
• Limited information exists regarding the interaction between tacrine and Kv2.1 channels.

Purpose of the Study:

• To investigate the effects of tacrine on Kv2.1 channels.
• To explore the impact of tacrine on cell proliferation in relation to Kv2.1 channel expression.

Main Methods:

• Quantitative PCR (PCR) was used to assess Kv2.1 mRNA levels following tacrine treatment.
• Whole-cell patch-clamp recordings were employed to measure Kv2.1 channel currents.
• WST-8 assays were conducted to evaluate cell proliferation rates.

Main Results:

• Tacrine significantly reduced Kv2.1 mRNA expression and corresponding channel currents in HEK293 cells.
• Cell proliferation rates in HEK293 cells expressing Kv2.1 channels were notably enhanced after 24-hour tacrine exposure.
• Similar effects on Kv2.1 expression and cell proliferation were observed in N2A cells.

Conclusions:

• Tacrine application leads to the downregulation of Kv2.1 channel expression.
• Tacrine treatment increases cell proliferation, potentially through its effects on Kv2.1 channels.
• The modulation of Kv2.1 channels by tacrine may offer a novel explanation for its neuroprotective properties.